390 related articles for article (PubMed ID: 24594197)
41. Recognition of the N-terminal histone H2A and H3 peptides by peptidylarginine deiminase IV.
Saiki M; Watase M; Matsubayashi H; Hidaka Y
Protein Pept Lett; 2009; 16(9):1012-6. PubMed ID: 19508226
[TBL] [Abstract][Full Text] [Related]
42. Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
Moelants EA; Mortier A; Grauwen K; Ronsse I; Van Damme J; Proost P
Cytokine; 2013 Jan; 61(1):161-7. PubMed ID: 23075670
[TBL] [Abstract][Full Text] [Related]
43. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
44. ABAP: antibody-based assay for peptidylarginine deiminase activity.
Zendman AJ; Raijmakers R; Nijenhuis S; Vossenaar ER; Tillaart Mv; Chirivi RG; Raats JM; van Venrooij WJ; Drijfhout JW; Pruijn GJ
Anal Biochem; 2007 Oct; 369(2):232-40. PubMed ID: 17716614
[TBL] [Abstract][Full Text] [Related]
45. The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis.
Chang HH; Dwivedi N; Nicholas AP; Ho IC
Arthritis Rheumatol; 2015 Sep; 67(9):2323-34. PubMed ID: 26019128
[TBL] [Abstract][Full Text] [Related]
46. Role of Peptidylarginine Deiminase 4 in Central Nervous System Diseases.
Geng H; An Q; Zhang Y; Huang Y; Wang L; Wang Y
Mol Neurobiol; 2023 Nov; 60(11):6748-6756. PubMed ID: 37480499
[TBL] [Abstract][Full Text] [Related]
47. Human Deiminases: Isoforms, Substrate Specificities, Kinetics, and Detection.
Amin B; Voelter W
Prog Chem Org Nat Prod; 2017; 106():203-240. PubMed ID: 28762090
[TBL] [Abstract][Full Text] [Related]
48. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.
Jang B; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
Prion; 2013; 7(1):42-6. PubMed ID: 23022892
[TBL] [Abstract][Full Text] [Related]
49. Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation.
Jin Z; Fu Z; Yang J; Troncosco J; Everett AD; Van Eyk JE
Proteomics; 2013 Sep; 13(17):2682-91. PubMed ID: 23828821
[TBL] [Abstract][Full Text] [Related]
50. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
51. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin.
Ishigami A; Ohsawa T; Asaga H; Akiyama K; Kuramoto M; Maruyama N
Arch Biochem Biophys; 2002 Nov; 407(1):25-31. PubMed ID: 12392711
[TBL] [Abstract][Full Text] [Related]
52. Citrullination of myofilament proteins in heart failure.
Fert-Bober J; Giles JT; Holewinski RJ; Kirk JA; Uhrigshardt H; Crowgey EL; Andrade F; Bingham CO; Park JK; Halushka MK; Kass DA; Bathon JM; Van Eyk JE
Cardiovasc Res; 2015 Nov; 108(2):232-42. PubMed ID: 26113265
[TBL] [Abstract][Full Text] [Related]
53. Citrullination by peptidylarginine deiminase in rheumatoid arthritis.
Suzuki A; Yamada R; Yamamoto K
Ann N Y Acad Sci; 2007 Jun; 1108():323-39. PubMed ID: 17893996
[TBL] [Abstract][Full Text] [Related]
54. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
Yamada R; Suzuki A; Chang X; Yamamoto K
Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
[TBL] [Abstract][Full Text] [Related]
55. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
[TBL] [Abstract][Full Text] [Related]
56. Differential Protein Citrullination in Human ER- and ER+ Tumor and Adjacent Healthy Breast Tissue.
Tillotson J; Aryal B; Lai L; Beaver JA; Rao VA
Biochemistry; 2023 Feb; 62(4):893-898. PubMed ID: 36757899
[TBL] [Abstract][Full Text] [Related]
57. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
58. Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer's disease brains.
Ishigami A; Masutomi H; Handa S; Nakamura M; Nakaya S; Uchida Y; Saito Y; Murayama S; Jang B; Jeon YC; Choi EK; Kim YS; Kasahara Y; Maruyama N; Toda T
J Neurosci Res; 2015 Nov; 93(11):1664-74. PubMed ID: 26190193
[TBL] [Abstract][Full Text] [Related]
59. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin.
Tarcsa E; Marekov LN; Mei G; Melino G; Lee SC; Steinert PM
J Biol Chem; 1996 Nov; 271(48):30709-16. PubMed ID: 8940048
[TBL] [Abstract][Full Text] [Related]
60. Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Lee HJ; Joo M; Abdolrasulnia R; Young DG; Choi I; Ware LB; Blackwell TS; Christman BW
J Biol Chem; 2010 Dec; 285(51):39655-62. PubMed ID: 20937835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
